ESR1 and breast carcinoma: In one study assessing mRNA levels by TargetPrint, most breast carcinomas (five of eight cases) with 1–10% ER expression by IHC were negative by RNA analysis.25 In this study however, there were even more cases (n = 15) with negative IHC ER results that were ER positive by RNA analysis.